Dr. Paul Mendoza, M.D.
What this data tells you about Dr. Mendoza
Dr. Paul Mendoza is a rheumatology specialist in Palm Beach Gardens, FL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Mendoza performed 127,129 Medicare services across 2,829 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mendoza received a total of $9,103 from 28 pharmaceutical and/or device companies across 538 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mendoza is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) | 54,800 | $4 | $14 |
| Denosumab injection (Prolia/Xgeva) | 19,740 | $18 | $28 |
| Romosozumab injection (Evenity) for osteoporosis | 19,320 | $8 | $13 |
| Golimumab infusion (Simponi Aria) | 12,600 | $11 | $35 |
| Abatacept infusion (Orencia) | 4,875 | $33 | $62 |
| Steroid injection (triamcinolone) | 4,478 | $1 | $5 |
| Office visit, established patient (30-39 min) | 2,632 | $96 | $155 |
| Infliximab infusion (Remicade) | 2,100 | $26 | $57 |
| Injection, rituximab, 10 mg | 2,071 | $64 | $110 |
| Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | 1,800 | $13 | $36 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 695 | $58 | $95 |
| Joint injection, major joint | 589 | $42 | $109 |
| Administration of chemotherapy into vein, 1 hour or less | 261 | $104 | $200 |
| Aspiration and/or injection of fluid from small joint | 245 | $28 | $83 |
| New patient office visit (45-59 min) | 183 | $121 | $210 |
| Injection of trigger points, 1-2 muscles | 121 | $32 | $84 |
| Telephone medical discussion with physician, 11-20 minutes | 116 | $68 | $115 |
| Administration of chemotherapy into vein, each additional hour | 95 | $23 | $85 |
| Telephone medical discussion with physician, 5-10 minutes | 75 | $39 | $75 |
| Injection, zoledronic acid, 1 mg | 55 | $7 | $20 |
| Drug injection, under skin or into muscle | 50 | $11 | $35 |
| Injection of additional new drug or substance into vein | 36 | $12 | $45 |
| Injection of anesthetic agent and/or steroid into lower back and leg nerve (sciatic nerve) | 30 | $152 | $335 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 26 | $4 | $10 |
| Injection of trigger points, 3 or more muscles | 25 | $42 | $95 |
| Aspiration and/or injection of fluid from medium joint | 24 | $37 | $90 |
| Complete ultrasound scan of joint | 22 | $9 | $150 |
| Injection into tendon at attachment to bone or muscle | 21 | $38 | $89 |
| Injection into tendon or ligament | 20 | $37 | $105 |
| Office visit, established patient (20-29 min) | 13 | $68 | $110 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 11 | $52 | $100 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
4.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Mendoza is a mixed practice specialist, with above-average Medicare volume (top 18% in FL), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Mendoza experienced with certolizumab injection (cimzia)?
Does Dr. Mendoza receive payments from pharmaceutical companies?
How do Dr. Mendoza's costs compare to other rheumatologists in Palm Beach Gardens?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology